Workflow
Newsfile
icon
Search documents
KMX SECURITIES ALERT: BFA Law Notifies CarMax, Inc. Investors of Important January 2 Securities Class Action Deadline
Newsfile· 2025-11-17 20:18
KMX SECURITIES ALERT: BFA Law Notifies CarMax, Inc. Investors of Important January 2 Securities Class Action DeadlineNovember 17, 2025 3:18 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 17, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the p ...
CSE Bulletin: Name Change - First American Uranium Inc. (NIOB)
Newsfile· 2025-11-17 20:03
Toronto, Ontario--(Newsfile Corp. - Le 17 novembre/November 2025) - First American Uranium Inc. has announced a name change to North American Niobium and Critical Minerals Corp. Shares will begin trading under the new name and with a new CUSIP number on November 20, 2025. The symbol will remain the same. Disclosure documents are available at www.thecse.com. Please note that all open orders will be cancelled at the end of business on November 19, 2025. Dealers are reminded to re-enter their orders. ...
Golden Sky Minerals Corp. Shareholders Approve Option and Joint Venture Agreement with Boliden
Newsfile· 2025-11-17 19:43
Core Viewpoint - Golden Sky Minerals Corp. has successfully secured shareholder approval for a significant Option and Joint Venture Agreement with Boliden Mineral Canada Ltd., which is expected to enhance the company's growth strategy and exploration potential in British Columbia [1][2][3]. Agreement Details - The Agreement allows Boliden to earn an 80% interest in Golden Sky's Rayfield copper-gold property by funding C$20 million in exploration expenditures over staged milestones [2]. - The combined land package of Rayfield and Boliden's Gjoll Property spans approximately 90,000 hectares in the Quesnel Trough, creating a district-scale exploration opportunity [2]. Strategic Implications - This partnership is a cornerstone of Golden Sky's growth strategy, reducing financial risk and minimizing equity dilution while retaining a 20% interest during the discovery phase [3]. - Boliden's funding commitment preserves Golden Sky's share structure, allowing the company to maintain 100% ownership of the Rayfield Property until Boliden exercises the option [3]. Exploration Plans - Ongoing collaboration has already initiated groundwork, including airborne geophysics and geochemical surveys, with drilling planned for high-priority targets [4]. - The partnership aims to execute an ambitious 2026 exploration program, focusing on geophysical and geochemical surveys, geological mapping, and initial drilling campaigns [4]. Company Overview - Golden Sky Minerals Corp. is a junior explorer focused on acquiring and developing mineral properties in mining-friendly districts, with a portfolio that includes the Rayfield-Gjoll Project and other gold projects in Canada [6][7].
Silver Bullet Mines Announces Second Shipment of Commercial Gold/Silver Concentrate
Newsfile· 2025-11-17 19:12
Core Viewpoint - Silver Bullet Mines Corp. has successfully processed and shipped high-grade gold/silver concentrates from its KT Gold Mine in Arizona, with ongoing plans for regular shipments to the Buyer [1][2][4]. Shipment Details - The first shipment consisted of approximately 4000 pounds of concentrate from the KT Gold Mine, received by the Buyer on October 29 [1]. - A second shipment of about 2500 pounds from the KT Gold Mine is scheduled for pickup this week [2]. - The Company is processing additional surface material from the KT Gold Mine to support a third shipment, aiming for biweekly shipments of 2500 to 4000 pounds each [4]. Assay Results and Concentrate Quality - Initial assay results from the SC Mine indicate all concentrate samples tested returned values above detection limits, but the Company sees greater value in concentrates from the KT Mine and will not allocate significant resources to the SC Mine at this time [6]. - The Company is awaiting the Buyer's assay results to determine the precise value of the shipments [5]. Processing and Production Insights - The Company utilizes gravitational processes to separate metals with higher specific gravity, such as gold and silver, from the host material [9]. - The focus is on producing high-grade concentrates to minimize refining and transportation costs, although the concentration ratio for the KT Mine is not yet established [8][12]. Management and Corporate Updates - John MacKenzie has rejoined the board of directors, bringing extensive experience in the mining and metals industry [13]. - The Company has issued 258,675 shares as interest payment related to outstanding debentures [14].
ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Western Alliance Bancorporation Investors to Inquire About Securities Class Action Investigation - WAL
Newsfile· 2025-11-17 19:05
Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Western Alliance Bancorporation due to allegations of materially misleading business information [1] Group 1: Legal Actions and Stock Performance - Western Alliance Bancorporation initiated a lawsuit against Cantor Group V LLC for fraud related to collateral loans, resulting in a 10.88% stock price drop on October 16, 2025 [3] Group 2: Class Action Information - Investors who purchased Western Alliance Bancorporation securities may be entitled to compensation through a class action without any out-of-pocket fees, with Rosen Law Firm preparing to seek recovery of investor losses [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and recovering hundreds of millions for investors [4]
CYTK DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK
Newsfile· 2025-11-17 18:44
Core Viewpoint - Rosen Law Firm is encouraging investors of Cytokinetics, Inc. to secure legal counsel before the November 17, 2025 deadline for a securities class action lawsuit related to the company's stock [1]. Group 1: Class Action Details - Investors who purchased Cytokinetics common stock between December 27, 2023, and May 6, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and potential lead plaintiffs must move the Court by November 17, 2025 [3]. - The lawsuit alleges that Cytokinetics made false or misleading statements regarding the timeline for the New Drug Application (NDA) submission and approval process for aficamten, specifically regarding expected FDA approval in the second half of 2025 [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions of dollars for investors [4].
CSE Bulletin: Consolidation - Arctic Fox Lithium Corp. (AFX)
Newsfile· 2025-11-17 18:28
Core Points - Arctic Fox Lithium Corp. has announced a consolidation of its issued and outstanding common shares at a ratio of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares [1][2][3] - The total number of outstanding shares will be reduced to approximately 7,046,738 common shares following the consolidation [1][3] - The company's name and trading symbol will remain unchanged despite the consolidation [1][3] Trading Information - All open orders will be canceled at the close of business on November 17, 2025, and dealers are advised to re-enter their orders considering the share consolidation [2][3] - Trading on a consolidated basis will commence on November 18, 2025 [4] - The record date and anticipated payment date for the consolidation is also set for November 18, 2025 [4] - The new trading symbol will be AFX, with a new CUSIP of 03967C 20 7 and a new ISIN of CA 03967C 20 7 6 [4]
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
Newsfile· 2025-11-17 17:47
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In MoonLake To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in MoonLake between March 10, 2024 and September 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - November 17 ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
Newsfile· 2025-11-17 17:15
Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against aTyr Pharma, Inc. due to allegations of misleading statements regarding the efficacy of its drug Efzofitimod, which led to significant financial losses for investors [2][5]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in aTyr between January 16, 2025, and September 12, 2025, to discuss their legal options [1]. - There is a deadline of December 8, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against aTyr [2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4]. Group 2: Allegations Against aTyr - The complaint alleges that aTyr and its executives violated federal securities laws by making false and misleading statements about Efzofitimod, particularly regarding its ability to allow patients to taper off steroids completely [5]. - In the EFZO-FIT study, efzofitimod showed no significant change in mean daily oral corticosteroid dose at week 48, with a reduction of 2.79 mg for the drug compared to 3.52 mg for placebo [6]. - Following the release of the study results, aTyr's stock plummeted by 83.25%, dropping from $6.03 to $1.01 [6].
Besra Gold Announces Board Changes
Newsfile· 2025-11-17 16:24
Perth, Western Australia--(Newsfile Corp. - November 17, 2025) - Besra Gold Inc (ASX: BEZ) (Besra or the Company) announces that David Izzard has today resigned as a Director of the Company.The Board wishes to express its sincere appreciation for the very considerable contribution David has made to the Company's strategies, direction, development, and governance since his appointment as a Director and Chair of the Company on 24 June 2025.In accordance with ASX Listing Rule 3.16.1, the Board advises that Mr ...